• Markets
    • icon
  • Companies
GSS · ASX

Genetic Signatures Ltd. (ASX:GSS)

AU$0.5

 -0.015 (-2.913%)
ASX:Live
30/11/2023 04:10:33 PM
HALO Ords HALO Consensus Value GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

GSS Overview

GSS Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About GSS

Website

Genetic Signatures Ltd.

Telephone

61.2.9870.7580

Address

7 Eliza Street Newtown, New South Wales (NSW) 2042

Description

Genetic Signatures Ltd. is a molecular diagnostics company, which focuses on the development of real-time PCR based products for the routine detection of infectious diseases. Its molecular diagnostics, 3Base, provides high-volume hospital and pathology laboratories with the ability to screen wide array of infectious pathogens. The firm also designs and manufactures suite of real-time polymerase chain reaction based products for the routine detection of infectious diseases under the EasyScreen brand. The company was founded by Robert J. Birrell, Christopher M. Abbott, and Geoffrey Grigg on February 15, 2001 and is headquartered in Newtown, Australia.

GSS Price Chart

Key Stats

Market Cap

AU$72.42M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.44 - 1.0

Trade Value (12mth)

AU$14,067.00

1 week

4.04%

1 month

3%

YTD

-42.78%

1 year

-43.09%

All time high

2.94

Key Fundamentals

EPS 3 yr Growth

497.600%

EBITDA Margin

-102.50%

Operating Cashflow

-$12m

Free Cash Flow Return

-25.50%

ROIC

-28.80%

Interest Coverage

-17,365.00

Quick Ratio

4.50

Other Data

Shares on Issue (Fully Dilluted)

143m

HALO Sector

Industrials

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.10

GSS Announcements

Latest Announcements

Date Announcements

31 October 22

Change of Registry Address

×

Change of Registry Address

31 July 23

Quarterly update and Appendix 4C

×

Quarterly update and Appendix 4C

31 August 23

Appendix 4E and Annual Report

×

Appendix 4E and Annual Report

31 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

31 August 22

Full Year Statutory Accounts

×

Full Year Statutory Accounts

30 September 22

Annual Report to shareholders

×

Annual Report to shareholders

30 September 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 October 23

Quarterly update and Appendix 4C

×

Quarterly update and Appendix 4C

30 March 22

Public Health Wales Awards Enteric Testing Contract to GSS

×

Public Health Wales Awards Enteric Testing Contract to GSS

30 January 23

Quarterly update and Appendix 4C

×

Quarterly update and Appendix 4C

29 September 22

3base Kit for Antimicrobial Resistance Shows High Detection

×

3base Kit for Antimicrobial Resistance Shows High Detection

29 October 18

2018 Annual Report to Shareholders

×

2018 Annual Report to Shareholders

29 October 18

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 November 23

2023 AGM Chairman's Address and CEO Presentation

×

2023 AGM Chairman's Address and CEO Presentation

29 November 23

AGM Results of Meeting

×

AGM Results of Meeting

29 November 18

Withdrawal of resolution 4 from 2018 Annual General Meeting

×

Withdrawal of resolution 4 from 2018 Annual General Meeting

29 November 18

Results of Annual General Meeting

×

Results of Annual General Meeting

29 November 16

2016 AGM MD and CEO Presentation

×

2016 AGM MD and CEO Presentation

29 May 20

Investor Presentation

×

Investor Presentation

28 September 15

Date of Annual General Meeting

×

Date of Annual General Meeting

28 October 19

Investor presentation - capital raise

×

Investor presentation - capital raise

28 October 16

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 16

Annual Report to shareholders

×

Annual Report to shareholders

28 November 17

2017 AGM Presentation

×

2017 AGM Presentation

28 July 20

Investor presentation

×

Investor presentation

28 January 22

Investor presentation

×

Investor presentation

28 August 20

Investor presentation

×

Investor presentation

28 August 20

CEO presenting at ShareCafe webinar

×

CEO presenting at ShareCafe webinar

GSS Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.0 74.0 -557.9 Lock Lock Lock
     PE X Lock Lock Lock Lock 149.0 44.3 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 70.4 0.0 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.04 -0.07 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.06 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 651.8 4.8 -267.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.3 4.8 -19.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.35 0.38 0.30 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.34 0.37 0.26 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 8.2 -29.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 146 145 143 Lock Lock Lock
Basic m Lock Lock Lock Lock 143 143 143 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 28 35 17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 151.1 25.2 -52.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 4 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 7 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 280.5 68.9 -276.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.1 20.4 -75.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 85 80 175 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 5 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.6 53.7 -478.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.5 12.9 -102.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 3 -19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 132.2 90.6 -736.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.5 8.4 -111.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 3 -18 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 3 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 184.2 74.4 -558.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.2 8.6 -83.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 4 10 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 3 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -5 -3 -8 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 8 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 96.1 1,866.8 -277.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.2 -0.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 30 37 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 54 60 49 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -30 -37 -16 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 5 5 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 49 55 43 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 49 55 43 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.6 10.9 -21.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 3.2 5.7 -38.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 3.7 5.9 -28.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 8.8 18.8 -25.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 82.8 241.2 -17,365.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -10.0 -8.0 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -60.2 -67.3 -38.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 10.3 10.7 6.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.7 8.5 4.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 63.2 72.0 45.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 90.7 204.1 -205.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.3 7.5 2.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.5 2.5 3.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 0.8 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.7 9.6 22.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.2 8.6 -109.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 3.2 5.1 -37.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 147.3 144.5 116.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 84.8 49.0 165.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 232.2 193.5 282.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.6 42.9 46.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 203.5 150.6 236.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.10%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

GSS Shortsell

Frequently Asked Questions

The current share price of Genetic Signatures Ltd. (GSS:ASX) is AU$0.5.
The 52-week high share price for Genetic Signatures Ltd. (GSS:ASX) is AU$1.00.
The 52-week low share price for Genetic Signatures Ltd. (GSS:ASX)? is AU$0.44.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) has a franking level of 0%.
Genetic Signatures Ltd. (GSS:ASX) is classified in the Industrials.
The current P/E ratio for Genetic Signatures Ltd. (GSS:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.